218 related articles for article (PubMed ID: 38516408)
1. Colitis-associated neoplasia: molecular basis and clinical translation.
Foersch S; Neurath MF
Cell Mol Life Sci; 2014 Sep; 71(18):3523-35. PubMed ID: 24830703
[TBL] [Abstract][Full Text] [Related]
2. ERCC4: a potential regulatory factor in inflammatory bowel disease and inflammation-associated colorectal cancer.
Shi R; Wang S; Jiang Y; Zhong G; Li M; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1348216. PubMed ID: 38516408
[TBL] [Abstract][Full Text] [Related]
3. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease and carcinogenesis.
Nagao-Kitamoto H; Kitamoto S; Kamada N
Cancer Metastasis Rev; 2022 Jun; 41(2):301-316. PubMed ID: 35416564
[TBL] [Abstract][Full Text] [Related]
5. Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology.
Yin Y; Wan J; Yu J; Wu K
Inflamm Bowel Dis; 2023 Oct; 29(10):1648-1657. PubMed ID: 37202830
[TBL] [Abstract][Full Text] [Related]
6. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U
Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120
[TBL] [Abstract][Full Text] [Related]
7. Inter-individual variation in nucleotide excision repair pathway is modulated by non-synonymous polymorphisms in ERCC4 and MBD4 genes.
Allione A; Guarrera S; Russo A; Ricceri F; Purohit R; Pagnani A; Rosa F; Polidoro S; Voglino F; Matullo G
Mutat Res; 2013; 751-752():49-54. PubMed ID: 24004570
[TBL] [Abstract][Full Text] [Related]
8. The Mechanism of Ubiquitination or Deubiquitination Modifications in Regulating Solid Tumor Radiosensitivity.
Zhang M; Shao Y; Gu W
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137461
[TBL] [Abstract][Full Text] [Related]
9. Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease.
Temby M; Boye TL; Hoang J; Nielsen OH; Gubatan J
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002302
[TBL] [Abstract][Full Text] [Related]
10. The influence of microbiota on ferroptosis in intestinal diseases.
Yao T; Li L
Gut Microbes; 2023 Dec; 15(2):2263210. PubMed ID: 37795964
[TBL] [Abstract][Full Text] [Related]
11. The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies.
Xu J; Shi Q; Wang B; Ji T; Guo W; Ren T; Tang X
Front Immunol; 2023; 14():1257254. PubMed ID: 37720221
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapies: advances and bottlenecks.
Rui R; Zhou L; He S
Front Immunol; 2023; 14():1212476. PubMed ID: 37691932
[TBL] [Abstract][Full Text] [Related]
13. A novel role of the splenic volume in Crohn's disease: evaluating the efficacy of infliximab.
Shi X; Wang JH; Rao SX; Liu TT; Wu H
Front Pharmacol; 2023; 14():1246657. PubMed ID: 37663264
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]